GLIDE
Latest Content
Please check back later for more content.
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Dermatology Conferences and Meetings Calendar: December 2025
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
